Wellington Management Group
ORIC icon

Wellington Management Group’s Oric Pharmaceuticals ORIC Stock Holding History

Wellington Management Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Sell
186,099
-5,724
-3% -$65K ﹤0.01% 1522
2025
Q4 		$1.57M Buy
191,823
+41,229
+27% +$475K ﹤0.01% 1648
2025
Q3 		$1.81M Sell
150,594
-72,708
-33% -$765K ﹤0.01% 1657
2025
Q2 		$2.27M Buy
223,302
+45,085
+25% +$303K ﹤0.01% 1551
2025
Q1 		$994K Sell
178,217
-8,213
-4% -$71.8K ﹤0.01% 1711
2024
Q4 		$1.5M Buy
186,430
+12,042
+7% +$110K ﹤0.01% 1640
2024
Q3 		$1.79M Buy
174,388
+51,565
+42% +$510K ﹤0.01% 1569
2024
Q2 		$868K Buy
122,823
+10,850
+10% +$97.1K ﹤0.01% 1703
2024
Q1 		$1.54M Buy
111,973
+39,576
+55% +$470K ﹤0.01% 1582
2023
Q4 		$666K Buy
+72,397
New +$524K ﹤0.01% 1690

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group's ORIC Position: Q1 2026 in Review

Wellington Management Group reduced its Oric Pharmaceuticals (ORIC) stake by 3% in Q1 2026, selling an estimated $65K and leaving 186,099 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Wellington Management Group first reported a position in ORIC in Q4 2023 and has held it in 10 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Wellington Management Group held 186,099 shares of Oric Pharmaceuticals worth $2.36M as of Q1 2026.
  • Wellington Management Group sold 5,724 Oric Pharmaceuticals shares in Q1 2026, an estimated $65K.
  • Oric Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1522 holding.
  • Wellington Management Group first reported a position in Oric Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.